# Intranasal Esketamine to Maintain the Antidepressant Response to IV Racemic Ketamine

> **NCT04856124** · — · COMPLETED · sponsor: **Psych Atlanta** · enrollment: 10 (actual)

## Conditions studied

- Treatment Resistant Depression

## Interventions

- **DRUG:** Intranasal esketamine

## Key facts

- **NCT ID:** NCT04856124
- **Lead sponsor:** Psych Atlanta
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-09-01
- **Primary completion:** 2020-12-15
- **Final completion:** 2021-03-01
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2021-04-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04856124

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04856124, "Intranasal Esketamine to Maintain the Antidepressant Response to IV Racemic Ketamine". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04856124. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*